If you have Granulomatosis with Polyangiitis (GPA) or Microscopic Polyangiitis (MPA), you try not to let symptoms get in your way. You try as best you can to do things you want to do, whether it's spending time with friends and family or enjoying time outside.
Rituxan in combination with glucocorticoids is an FDA-approved treatment for adults with GPA and MPA and is used to help put your disease into remission.
Rituxan can help put your disease into remission
In the RAVE trial, 64% of patients taking Rituxan and glucocorticoids experienced remission at 6 months, compared with 53% of patients taking cyclophosphamide (control group). Rituxan may help put your disease into remission and control a disease flare. Talk with your doctor if Rituxan may be right for you. Keep in mind, individual results may vary.
It is important to remember that Rituxan can cause side effects and not everyone responds to Rituxan in the same way. Some people experience side effects during or after their Rituxan treatment.
Potential serious side effects
Some of these side effects, although rare, can be very serious, including severe infusion reactions, severe skin and mouth reactions, hepatitis B virus (HBV) reactivation, progressive multifocal leukoencephalopathy (PML), tumor lysis syndrome (TLS), and serious infections.
For important side effect information about Rituxan, please see the Medication Guide.